Analysis of signaling pathways and diseases using TaqMan® Arrays (96)


When studying signaling pathways or complex diseases, it is highly useful to examine the expression level of as many participating genes as possible. However, researchers are often disencouraged by the multitude of necessary assays and the considerable cost and time required for their analysis.

IMGM now offers a new service to circumvent these obstacles and to provide you with reliable and affordable gene expression data for your pathways or diseases of interest.

Our service is based on real-time PCR analysis by so-called Gene Signature Panels in 96-well format (TaqMan® Arrays (96)), where the array plates are pre-spotted with TaqMan® assays targeting the genes of interest as well as selected housekeeping genes.

Over 90 different Gene Signature Panels are available (supplied by Applied Biosystems), covering signaling pathways such as the EGF pathway or the NFkB pathway, and diseases such as Alzheimer’s disease or diabetes.

For a complete list of all currently available TaqMan® Array (96) Gene Signature Panels, please [click here] and follow the link „TaqMan® Arrays (96)“ - or - use this [direct link] to review available Gene Signature Panels.

If you are interested in a customized Gene Signature Panel containing yor gene panel of interest, please contact us to receive further information.

By using Gene Signature Panels, your samples are analyzed in a highly time- and cost-efficient manner: No tedious looking up of assays matching to pathway members or disease-related genes, no error-prone and time-consuming pipetting of multiple assay-sample combinations, no residual unneeded assay volumes.

For more information about this convenient service, please contact the IMGM team [here].

[back to Newsletter]